Migraine induction with calcitonin gene-related peptide in patients from erenumab trials
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Migraine induction with calcitonin gene-related peptide in patients from erenumab trials
Authors
Keywords
-
Journal
JOURNAL OF HEADACHE AND PAIN
Volume 19, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-08
DOI
10.1186/s10194-018-0927-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Erenumab (AMG 334) in episodic migraine
- (2017) Messoud Ashina et al. NEUROLOGY
- Pharmacokinetic-Pharmacodynamic Relationship of Erenumab (AMG 334) and Capsaicin-Induced Dermal Blood Flow in Healthy and Migraine Subjects
- (2017) Thuy Vu et al. PHARMACEUTICAL RESEARCH
- Calcitonin gene-related peptide induced migraine attacks in patients with and without familial aggregation of migraine
- (2016) Song Guo et al. CEPHALALGIA
- Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2016) Hong Sun et al. LANCET NEUROLOGY
- Premonitory and nonheadache symptoms induced by CGRP and PACAP38 in patients with migraine
- (2016) Song Guo et al. PAIN
- Calcitonin Gene-Related Peptide Modulates Heat Nociception in the Human Brain - An fMRI Study in Healthy Volunteers
- (2016) Mohammad Sohail Asghar et al. PLoS One
- Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
- (2015) Marcelo E Bigal et al. LANCET NEUROLOGY
- Phosphodiesterase 3 inhibitor cilostazol induces migraine-like attacks via cyclic AMP increase
- (2014) Song Guo et al. BRAIN
- Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study
- (2014) David W Dodick et al. LANCET NEUROLOGY
- Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
- (2014) David W Dodick et al. LANCET NEUROLOGY
- Calcitonin Gene-Related Peptide: Physiology and Pathophysiology
- (2014) F. A. Russell et al. PHYSIOLOGICAL REVIEWS
- The International Classification of Headache Disorders, 3rd edition (beta version)
- (2013) CEPHALALGIA
- Differentiation of Nerve Fibers Storing CGRP and CGRP Receptors in the Peripheral Trigeminovascular System
- (2013) Sajedeh Eftekhari et al. JOURNAL OF PAIN
- Calcitonin gene-related peptide (CGRP) and its receptor components in human and rat spinal trigeminal nucleus and spinal cord at C1-level
- (2012) Sajedeh Eftekhari et al. BMC NEUROSCIENCE
- Evidence for a vascular factor in migraine
- (2010) Mohammad S. Asghar et al. ANNALS OF NEUROLOGY
- Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura
- (2010) Jakob Møller Hansen et al. CEPHALALGIA
- Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion
- (2010) S. Eftekhari et al. NEUROSCIENCE
- EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force
- (2009) S. Evers et al. EUROPEAN JOURNAL OF NEUROLOGY
- PACAP38 induces migraine-like attacks in patients with migraine without aura
- (2008) Henrik Winther Schytz et al. BRAIN
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started